Status: Recruiting
An Experimental Study of Belzutifan Impact on Catecholamine Metabolism
To investigate the impact of a medication called Belzutifan on the production and subsequent metabolism of adrenaline and noradrenaline collectively termed 'catecholamines'. The study aims to identify changes in the production and metabolism of catecholamines by measuring the substance which starts the chain of catecholamine metabolism called tyrosine in patients before, during and after 5 days of taking Belzutifan 120mg daily.
Participants needed: 12
Trial details
Phase: Phase 2Biological sex: AllType: InterventionalSponsor: Cambridge University Hospitals NHS Foundation TrustUpdated: Jul 2, 2026Locations: 1
Eligibility criteria
Adult patients > 18 years [+3]
Has hypoxia, or requires intermittent supplemental oxygen, or requires chronic s... [+5]